• our expertise
    Industry
    Life Science Agribusiness/Food/Chemical Private Equity
    Business Functions
    Digital Strategy & Business Development Marketing & Sales Business Operations Product Development Organization & People
  • our independent professionals
  • knowledge
  • about us
  • our purpose and values
    Our Purpose Our Values
  • join us
    Who we are What we do Who we hire Why us? Our open roles
  • get in touch
  • login

Neil Grubert
Life Science
Europe

“
Working with a-connect as an independent professional gives me the opportunity to reach new clients, collaborate with industry experts and contribute to projects that have a material impact on customers’ businesses.

Neil Grubert

Life Science
Europe

profile

Neil is a pharmaceutical market access specialist with 26 years of experience tracking the global prescription drug and self-medication markets. In that time, he has provided advisory services to many of the world’s top 20 life sciences companies, as well as numerous mid-tier companies. In addition to conducting bespoke projects, he has authored more than 150 syndicated reports on market access, covering 20 mature and emerging markets, multiple therapeutic areas, and numerous industry issues, including a recently published major study on key market access trends in Europe. Neil is an experienced public speaker who has chaired events and delivered numerous presentations at conferences, seminars, webinars and training workshops. He is currently developing a series of multi-client training programs in market access. Neil previously spearheaded the development of Decision Resources Group’s international market access business, most recently as Vice President of Global Market Access Insights.

specialities

Pharmaceuticals
Biotechnology
Market access
Pricing and reimbursement
Healthcare systems

Become an IP Contact Us

Neil's articles

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 1: Why does it matter? - a guest article from Neil Grubert
Read More

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 2: What will happen before and after Brexit? - a guest article from Neil Grubert
Read More

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 3: Is there a silver lining to this cloud? - a guest article from Neil Grubert
Read More

request a call back

    a-connect linkedin profile

    a-connect

    Follows us on LinkedIn to view articles, news and updates from a-connect

    latest on twitter

    a-connect @aconnectEffect 27 Apr
    Every organisation in the world is dealing with the disruption and ‘new normal’ brought upon by #COVID19. We have c… https://t.co/swuddAlKVB
    a-connect @aconnectEffect 1 Apr
    Can 'organs-on-a-chip' help model and understand complicated #diseases? Biological engineers have created a multiti… https://t.co/vQ1Fw2Xlzq
    our expertise our independent professionals knowledge about us our values join us get in touch in the press login
    terms and conditions privacy notice cookie notice site credit